Pharmaceutical Research Expert Witnesses

Chemistry & Chemicals, Pharmaceutical Research - drug discovery, natural products chemistry, termite control, organic synthesis, lipid metabolism, sterol metabolism, fatty acid, phospholipid, anti-cancer drug, cholesterol, hyaluronic acid, polymers, insect pheromone, hormone biochemistry, biomaterials, regenerative medicine, intellectual property

Expert witness and consultant for intellectual property cases in the chemical and life sciences. Expert in organic synthesis, natural products chemistry, mechanistic enzymology, pest control agents, termite biology, insect and mammalian pheromone biochemistry, insect hormone biochemistry, mammalian and insect steroid metabolism, and photoaffinity labeling and intracellular visualization. Chemical biology of phosphoinositide and lysophosphatidic acid signaling; the chemistry of hyaluronic acid and development of hyaluronic acid derived biomaterials for wound repair, cell culture, tissue engineering. Discovery of anti-cancer, cholesterol-lowering, and anti-inflammatory drugs.

Pharmaceutical Research, Chemistry & Chemicals - Drug Formulation, Biotechnology, liquid formulation, medicinal chemist, organic chemist, pharmcokinetics, stability studies, dietary supplements, tetracyclines, synthetic biology, breathalyzer, drug tests

PHARMACEUTICAL EXPERIENCE Dr. Abato is a Medicinal Chemist. His expertise includes drug research, medicinal chemistry, organic chemistry, drug formulation for; IT, IV, IP, ICV, IN, IM and oral dosing routs, stability studies, extensive structure-activity relationships, efficacy, pharmacokinetics, as well as all pre-clinical testing required for IND submission to the FDA. Dr Abato was awarded the prestigious “Heroes of Chemistry Award” by the American Chemical Society in 2019 for his contribution to NUZYRA, the latest antibiotic that works on antibacterial resistant bacteria. Additionally, he has developed qualified clinical candidates for Spinal Muscular Atrophy (SMA) and Multiple Sclerosis. As a Medicinal Chemist, Dr Abato has also conducted research in the areas of Malaria, Tuberculosis and Cancer. PHARMACEUTICAL CONSULTING Dr Abato provides consulting services for medicinal chemistry, drug formulation, chemistry manufacturing and controls, literature search/summary and manag...

Toxicology, Pharmaceutical Research - Pharmacology, Neuroscience, Contract Research Organizations, Academic Research, Drug Development, Drug Due Diligence, Human Health Risk Assessment, Diplomate of the American Board of Toxicology, DABT, US FDA, US EPA, Gene Therapy, Biologics

I have 15 years of experience working with big and small sized companies in the biotech, pharmaceutical and chemical industries to address pharmacology/toxicology and regulatory affairs issues. I have more than 30 years of research, consulting and regulatory experience. I have extensive experience interacting with national and international CROs, developing IND-enabling strategies for small and large molecules as well as biologics and gene therapies, developing protocols, study monitoring, reviewing and summarizing both GLP and non-GLP nonclinical pharmacology and toxicology data as well as other published scientific data. I have experience with human health safety assessments. I also have experience interacting with regulatory agencies and regulators. I am an active member of the American College of Toxicology, Society of Toxicology, and American Society of Gene and Cell Therapies. I also am a Diplomate of the American Board of Toxicology (DABT) since 2018.

Pharmacology- Clinical, Pharmaceutical Research - Forensic Pharmacology, Toxicology

I am an Associate Professor and Chair; as well as former Chair of the Medical IRB. As a forensic pharmacologist, my role is to analyze, assess, review, and support the attorney's position. I am recognized as an expert witness in pharmacology and toxicology for deposition and trial testimonies (Criminal, Civil and Military courts; both Plaintiff and Defense). My area of expertise includes a broad range of cases such as blood alcohol level (BAL), DUI, adverse drug reactions to medicines, overdose of medicines, drug interactions, and personal injury resulting from an exposure to medicines, effects from drug abuse or industrial chemicals, and induction of cancer by chemicals. I have provided written reports and in the case of a trial, I have testified to clearly explain the findings in the court. I view my role as a forensic pharmacologist involving helping the attorney in preparing a cross-examination of the expert on the opposite side.

Toxicology, Pharmaceutical Research - Pharmacology, Neuroscience, Contract Research Organizations, Academic Research, Drug Development, Drug Due Diligence, Human Health Risk Assessment, Diplomate of the American Board of Toxicology, DABT, US FDA, US EPA, Gene Therapy, Biologics

I have 15 years of experience working with big and small sized companies in the biotech, pharmaceutical and chemical industries to address pharmacology/toxicology and regulatory affairs issues. I have more than 30 years of research, consulting and regulatory experience. I have extensive experience interacting with national and international CROs, developing IND-enabling strategies for small and large molecules as well as biologics and gene therapies, developing protocols, study monitoring, reviewing and summarizing both GLP and non-GLP nonclinical pharmacology and toxicology data as well as other published scientific data. I have experience with human health safety assessments. I also have experience interacting with regulatory agencies and regulators. I am an active member of the American College of Toxicology, Society of Toxicology, and American Society of Gene and Cell Therapies. I also am a Diplomate of the American Board of Toxicology (DABT) since 2018.

DNA, Laboratories & Testing - Forensic Science, Pharmaceutical Research, Bioengineering, Biomedical Engineering, Biochemistry, Chemistry, Bacteria, Infection, DNA, Biological Engineering, Testing and Laboratories, Infectious Disease research, Laboratory, Vaccine, Vaccine development

Dr. Byrd is an scientific executive and former senior military officer with significant civil and criminal legal consulting experience including deposition and trial testimony. He has held multiple scientific lead positions including Director of Biosciences at the Army Research Laboratory and Lead Scientific Advisor to the Chief of Staff of the Army and has extensive expertise in biotechnology, chemistry, and life science research processes. . He has also worked as a professor of chemistry, biochemistry, and biology and has collaborated in research efforts with federal, academic, and industry partners such as DARPA, DHS, FBI, MIT, UCSB, and MedImmune, among others. His areas of expertise include: ➢ Bioengineering ➢ Biochemistry ➢ Forensic Science ➢ Microbiology ➢ DNA and Nucleic Acids ➢ Vaccine Development ➢ Research and Development ➢ Biotechnology ➢ Pharmaceutical Development ➢ Bacteria and infection ➢ Laboratory documentation and research review

Toxicology, Pharmaceutical Research - Pharmacology, Neuroscience, Contract Research Organizations, Academic Research, Drug Development, Drug Due Diligence, Human Health Risk Assessment, Diplomate of the American Board of Toxicology, DABT, US FDA, US EPA, Gene Therapy, Biologics

I have 15 years of experience working with big and small sized companies in the biotech, pharmaceutical and chemical industries to address pharmacology/toxicology and regulatory affairs issues. I have more than 30 years of research, consulting and regulatory experience. I have extensive experience interacting with national and international CROs, developing IND-enabling strategies for small and large molecules as well as biologics and gene therapies, developing protocols, study monitoring, reviewing and summarizing both GLP and non-GLP nonclinical pharmacology and toxicology data as well as other published scientific data. I have experience with human health safety assessments. I also have experience interacting with regulatory agencies and regulators. I am an active member of the American College of Toxicology, Society of Toxicology, and American Society of Gene and Cell Therapies. I also am a Diplomate of the American Board of Toxicology (DABT) since 2018.

Obstetrics & Gynecology, Pharmaceutical Research - Women's Health

Certified Physician Executive; Certified Physician Investigator; Fellow of the American College of Obstetrics & Gynecology; Fellow of the American College of Surgeons

Public Health, Pharmaceutical Research - epidemiology, pharmacoepidemiology, outcomes research, observational research, real world evidence

Eileen E. Ming, MPH, ScD, FISPE, is an epidemiologist, pharmacoepidemiologist, outcomes researcher, and leader in the pharmaceutical industry. She served as an outcomes researcher at Merck, an epidemiologist at AstraZeneca, and the head of global epidemiology and pharmacoepidemiology at Shire Pharmaceuticals. Dr. Ming founded Epi Excellence, an epidemiology consulting practice, in 2014. She has worked across a variety of therapeutic areas, from pre-clinical through post-marketing phases, providing epidemiologic strategic and tactical expertise to commercial, clinical development, market access, medical affairs, regulatory, and pharmacovigilance activities. Dr. Ming is an Adjunct Scholar of the Center for Clinical Epidemiology and Biostatistics, and an Adjunct Investigator of the Center for Pharmacoepidemiology Research and Training, at the Perelman School of Medicine at the University of Pennsylvania. She is a Fellow of the International Society for Pharmacoepidemiology. Dr. Ming r...

Pharmaceutical Research, Chemistry & Chemicals - Drug Formulation, Biotechnology, liquid formulation, medicinal chemist, organic chemist, pharmcokinetics, stability studies, dietary supplements, tetracyclines, synthetic biology, breathalyzer, drug tests

PHARMACEUTICAL EXPERIENCE Dr. Abato is a Medicinal Chemist. His expertise includes drug research, medicinal chemistry, organic chemistry, drug formulation for; IT, IV, IP, ICV, IN, IM and oral dosing routs, stability studies, extensive structure-activity relationships, efficacy, pharmacokinetics, as well as all pre-clinical testing required for IND submission to the FDA. Dr Abato was awarded the prestigious “Heroes of Chemistry Award” by the American Chemical Society in 2019 for his contribution to NUZYRA, the latest antibiotic that works on antibacterial resistant bacteria. Additionally, he has developed qualified clinical candidates for Spinal Muscular Atrophy (SMA) and Multiple Sclerosis. As a Medicinal Chemist, Dr Abato has also conducted research in the areas of Malaria, Tuberculosis and Cancer. PHARMACEUTICAL CONSULTING Dr Abato provides consulting services for medicinal chemistry, drug formulation, chemistry manufacturing and controls, literature search/summary and manag...

Pharmacist, Pharmacology- Clinical - Community Pharmacy, Pharmaceutical Research, Recreational Drugs, Medication Errors, Pharmacy Standards of Care, Drug Interactions, Pharmacy Practice

Scott received his initial training in pharmacy and has worked as a registered pharmacist since 1990. He spent several years as a research scientist in the pharmaceutical industry, receiving a number of patents, grants, and publications. His academic experience includes serving as a professor and administrator at several different pharmacy programs. He has served as an item writer and reviewer for both the Pharmacy College Admissions Test (PCAT) and the North American Pharmacist Licensure Examination (NAPLEX). In addition, he served as a fellow in the American Association of Colleges of Pharmacy (AACP) Academic Leaders Fellowship Program in 2011-12. Dr. Weston attended the University of Mississippi where he received a B.S. degree in Pharmacy in 1990. In 1995, he received a Doctor of Philosophy degree from the University of Mississippi in Pharmaceutical/Medicinal Chemistry and then completed a three-year postdoctoral fellowship at the Northwestern University Medical School in the De...

Psychiatry, Pharmaceutical Research - Psychiatric Adverse Reactions, Side Effects, Suicide, Homicide, Involuntary Intoxication

Dr. Josef Witt-Doerring is board-certified psychiatrist who specializes in the accurate identification of psychiatric adverse drug reactions. Currently, Dr. Witt-Doerring is the supervising Medical Director for telepsychiatric services for emergency room and consult-liaison psychiatry for HCA Healthcare's TriStar Division in Tennessee. Within this role, he oversees the quality of psychiatric care for 18 psychiatrists working in a division comprised of 11 hospitals and 4 freestanding emergency rooms. Dr. Witt-Doerring also sees outpatients in his private practice that focuses issues pertaining to psychiatric adverse reactions. Previously, Dr. Witt-Doerring served as a Medical Officer within the Division of Psychiatry at the Food and Drug Administration, where he analyzed emergent safety issues for psychiatric drugs and proposed strategies to mitigate risk. Before that, he completed a fellowship in Psychiatric Drug Development at Janssen Research & Development whilst also holdin...

Chemistry & Chemicals, Pharmaceutical Research - drug discovery, natural products chemistry, termite control, organic synthesis, lipid metabolism, sterol metabolism, fatty acid, phospholipid, anti-cancer drug, cholesterol, hyaluronic acid, polymers, insect pheromone, hormone biochemistry, biomaterials, regenerative medicine, intellectual property

Expert witness and consultant for intellectual property cases in the chemical and life sciences. Expert in organic synthesis, natural products chemistry, mechanistic enzymology, pest control agents, termite biology, insect and mammalian pheromone biochemistry, insect hormone biochemistry, mammalian and insect steroid metabolism, and photoaffinity labeling and intracellular visualization. Chemical biology of phosphoinositide and lysophosphatidic acid signaling; the chemistry of hyaluronic acid and development of hyaluronic acid derived biomaterials for wound repair, cell culture, tissue engineering. Discovery of anti-cancer, cholesterol-lowering, and anti-inflammatory drugs.